Client News

ABIVAX: FIRST US PATIENT ENROLLED IN GLOBAL PHASE 3 PROGRAM WITH OBEFAZIMOD IN ULCERATIVE COLITIS

ViGeneron presents preclinical data on intravitreal gene therapy of Stargardt disease at ESGCT

Andera Partners raises its largest life sciences fund at €456M, demonstrating the attractiveness of its activity and of the sector

HeartBeat.bio collaborates with Boehringer Ingelheim to investigate cardiac organoids for the development of new treatments for people with heart diseases

ONWARD Announces Topline Results from the LIFT Home Study Supporting Safety and Feasibility of ARC-EX Therapy to Treat People with Spinal Cord Injury at Home

Galapagos Biopharma: Dr. Sabine Koken geht als neue Steuerfrau bei Galapagos Biopharma Deutschland an Bord

Carbios strengthens its organization with a view to business development and integrates new expertise key to bringing its innovations to market

ABIVAX ANNOUNCES AD HOC ORDINARY AND EXTRAORDINARY GENERAL MEETING ON NOVEMBER 9, 2022

Carbios: 2022 half-year results

InflaRx Submits Request for Emergency Use Authorization to US FDA for Vilobelimab for Treatment of Critically Ill COVID-19 Patients